Combined pharmacotherapy and cognitive-behavioral therapy for anxiety disorders: Medication effects, glucocorticoids, and attenuated treatment outcomes.
- 8 June 2010
- journal article
- Published by American Psychological Association (APA) in Clinical Psychology: Science and Practice
- Vol. 17 (2), 91-103
- https://doi.org/10.1111/j.1468-2850.2010.01198.x
Abstract
[Clin Psychol Sci Prac 17: 91–103, 2010] Despite the success of both pharmacologic and cognitive‐behavioral interventions for the treatment of anxiety disorders, the combination of these modalities in adults has not resulted in substantial improvements in outcome relative to either strategy alone, raising questions about whether there are interfering effects that attenuate the magnitude of combination treatment benefits. In this article, we introduce an accounting of potential interference effects that expands upon arguments asserting the necessity of arousal for successful fear exposure. Specifically, recent advances in the study of the effects of cortisol on memory—suggesting that glucocorticoids are crucial to the learning of emotional material—have led us to posit that the attenuation of glucocorticoid activity by anxiolytic medications may interfere with extinction learning in exposure‐based therapies. Implications for the efficacy of combination treatments for the anxiety disorders are discussed.Keywords
This publication has 99 references indexed in Scilit:
- Cognitive Behavioral Therapy, Sertraline, or a Combination in Childhood AnxietyNew England Journal of Medicine, 2008
- Networks of neurons, networks of genes: An integrated view of memory consolidationNeurobiology of Learning and Memory, 2008
- Chronic Fluoxetine Treatment Induces Brain Region-Specific Upregulation of Genes Associated with BDNF-Induced Long-Term PotentiationNeural Plasticity, 2007
- Attenuation of the hypothalamic–pituitary–adrenal axis responsivity to the Trier Social Stress Test by the benzodiazepine alprazolamPsychoneuroendocrinology, 2006
- Glutamate NMDA Receptors within the Amygdala Participate in the Modulatory Effect of Glucocorticoids on Extinction of Conditioned Fear in RatsNeuropsychopharmacology, 2006
- The Promise of Extinction Research for the Prevention and Treatment of Anxiety DisordersBiological Psychiatry, 2006
- Alterations in Stress Reactivity After Long‐Term Treatment with Paroxetine in Women with Posttraumatic Stress DisorderAnnals of the New York Academy of Sciences, 2006
- Glucocorticoid enhancement of memory requires arousal-induced noradrenergic activation in the basolateral amygdalaProceedings of the National Academy of Sciences of the United States of America, 2006
- Microinfusions of Flumazenil into the Basolateral but Not the Central Nucleus of the Amygdala Enhance Memory Consolidation in RatsNeurobiology of Learning and Memory, 1999
- The acute effects of corticosteroids on cognition: integration of animal and human model studiesBrain Research Reviews, 1997